University of South Carolina

Scholar Commons
Faculty Publications

Environmental Health Sciences

10-2017

HMGB1-RAGE Pathway Drives Peroxynitrite Signaling-Induced IbdLike Inflammation in Murine Nonalcoholic Fatty Liver Disease
Varun Chandrashekaran
Ratanesh K. Seth
University of South Carolina, sethr@mailbox.sc.edu

Diptadip Dattaroy
Firas Alhasson
Jacek Ziolenka
Medical College of Wisconsin

See next page for additional authors

Follow this and additional works at: https://scholarcommons.sc.edu/
sph_environmental_health_sciences_facpub
Part of the Environmental Health Commons

Publication Info
Published in Redox Biology, Volume 13, 2017, pages 8-19.
© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).

This Article is brought to you by the Environmental Health Sciences at Scholar Commons. It has been accepted for
inclusion in Faculty Publications by an authorized administrator of Scholar Commons. For more information, please
contact digres@mailbox.sc.edu.

Author(s)
Varun Chandrashekaran, Ratanesh K. Seth, Diptadip Dattaroy, Firas Alhasson, Jacek Ziolenka, James
Carson, Franklin G. Berger, Balaraman Kalyanaraman, Anna Mae Diehl, and Saurabh Chatterjee

This article is available at Scholar Commons: https://scholarcommons.sc.edu/
sph_environmental_health_sciences_facpub/107

Redox Biology 13 (2017) 8–19

Contents lists available at ScienceDirect

Redox Biology
journal homepage: www.elsevier.com/locate/redox

Research Paper

HMGB1-RAGE pathway drives peroxynitrite signaling-induced IBD-like
inﬂammation in murine nonalcoholic fatty liver disease
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Recent clinical studies found a strong association of colonic inﬂammation and Inﬂammatory bowel disease
(IBD)-like phenotype with NonAlcoholic Fatty liver Disease (NAFLD) yet the mechanisms remain unknown. The
present study identiﬁes high mobility group box 1 (HMGB1) as a key mediator of intestinal inﬂammation in
NAFLD and outlines a detailed redox signaling mechanism for such a pathway. NAFLD mice showed liver
damage and release of elevated HMGB1 in systemic circulation and increased intestinal tyrosine nitration that
was dependent on NADPH oxidase. Intestines from NAFLD mice showed higher Toll like receptor 4 (TLR4)
activation and proinﬂammatory cytokine release, an outcome strongly dependent on the existence of NAFLD
pathology and NADPH oxidase. Mechanistically intestinal epithelial cells showed the HMGB1 activation of TLR4 was both NADPH oxidase and peroxynitrite dependent with the latter being formed by the activation of
NADPH oxidase. Proinﬂammatory cytokine production was signiﬁcantly blocked by the speciﬁc peroxynitrite
scavenger phenyl boronic acid (FBA), AKT inhibition and NADPH oxidase inhibitor Apocynin suggesting NADPH
oxidase-dependent peroxynitrite is a key mediator in TLR-4 activation and cytokine release via an AKT
dependent pathway. Studies to ascertain the mechanism of HMGB1-mediated NADPH oxidase activation showed
a distinct role of Receptor for advanced glycation end products (RAGE) as the use of inhibitors targeted against
RAGE or use of deformed HMGB1 protein prevented NADPH oxidase activation, peroxynitrite formation, TLR4
activation and ﬁnally cytokine release. Thus, in conclusion the present study identiﬁes a novel role of HMGB1
mediated inﬂammatory pathway that is RAGE and redox signaling dependent and helps promote ectopic
intestinal inﬂammation in NAFLD.

1. Introduction
Recent clinical reports suggest intestinal inﬂammation,
Inﬂammatory bowel disease-like phenotype (IBD) and neoplasia in
NAFLD cases [1–3]. These reports are in addition to the comorbidities
in cardiovascular system associated with fatty liver disease [4].
Emerging data have highlighted the co-existence of non-alcoholic fatty
liver disease (NAFLD) and inﬂammatory bowel disease; both of which
are increasingly prevalent disorders with signiﬁcant complications and
impact on future health burden [3]. With colorectal cancer the second
leading cause of morbidity and mortality, the clinical ﬁnding of colonic
inﬂammation and neoplasia in NAFLD is very signiﬁcant [2,5]. The

⁎

report also ﬁnds the association between nonalcoholic steatohepatitis,
the active form of NAFLD and colorectal neoplasms to be independent
of demographics and metabolic factors [2]. Although reports of a strong
intestinal inﬂammatory phenotype in NAFLD/NASH cases and a mutual
co-existence of liver inﬂammation in inﬂammatory bowel disease exist,
the cause of such ectopic manifestation remain poorly understood [3].
NAFLD has been shown to increase circulatory levels of cytokines
including adipokine leptin in the circulation, with the latter being
proinﬂammatory in nature [6]. However, evidence of leptin resistance
due to the attenuation of the JAK/STAT signaling pathway in peripheral tissues dampen its profound role in the intestine [7,8]. Recent
reports of other soluble molecular mediators of inﬂammation in NAFLD
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have emerged. These include several damage associated molecular
patterns like HMGB1, uric acid, extracellular ATP and NAD and has
been found to be prime causes of sterile inﬂammation in the liver and
other peripheral organs [9–17].
NAFLD/ NASH have often been associated with hepatocyte necrosis
primarily from abnormal triglyceride metabolism and resultant lipotoxicity [18]. Further, there is a tight link between JNK1-dependent
HMGB1 secretion from lipotoxic hepatocytes and a paracrine cytolytic
eﬀect on neighboring cholesterol-loaded hepatocytes operating via
TLR4 [18]. Interestingly HMGB1 can bind to TLR4 and generate a
similar inﬂammatory response though the binding of lipopolysaccharide is preferred over HMGB1 [19].
High mobility group box 1 (HMGB1) is a non-histone protein
involved in maintaining the architecture of chromatin. HMGB1 also
acts extracellularly as a cytokine, in processes such as inﬂammation,
cell migration and stem cell recruitment. Plasma HMGB1 level at
admission is an indicator of the severity of illness and a useful mortality
predictor in exertional heatstroke [20]. HMGB1 circulatory levels have
been predictors of outcome in neuroinﬂammation, ischemia reperfusion
injury and sepsis [11,21–25]. We and others have shown that HMGB1
circulatory levels are increased in NASH and are found to contribute in
the pathology of liver lobule and tubular toxicity [11,15].
Though circulatory levels of HMGB1 has been associated with
pathology, the signaling pathways, its association with pattern recognition receptors in the intestine following liver injury has never been
explored. HMGB1 can bind to both TLR4 and RAGE and has been
extensively reviewed by Weber et. al [19]. Their binding abilities
depend on the redox states of HMGB1 [19]. The reduced form contains
a thiol group at all three cysteine residues with a serum half-life of
17 min. It is this form that can bind to RAGE and activate inﬂammatory
pathways [19]. The present study tested the hypothesis that NAFLD
leads to an increase in circulatory HMGB1 levels triggering inﬂammatory pathways in the intestine. Mechanistically HMGB1 binds to RAGE
in the distal intestine and activates TLR4 translocation to lipid rafts via
a peroxynitrite dependent manner. The study reports a novel redoximmune crosstalk in a murine model of NAFLD and helps understand a
possible complicated relationship of innate immune interaction in
NAFLD-induced ectopic intestinal inﬂammation and IBD-like phenotype.

manufacturer's protocol. The primary antibodies were used at 1:250
dilutions. Antigen-speciﬁc immunohistochemistry was performed using
Vectastain Elite ABC kit (Vector Laboratories, Burlingame, CA) following manufacturer's protocols. 3,3′ Diaminobenzidine (Sigma-Aldrich)
was used as a chromogen substrate. Sections were counter-stained by
Mayer's hematoxylin (Sigma-Aldrich). For immunoﬂuorescence assays
the cells were then incubated with compatible AlexaFlour conjugated
secondary antibodies from Invitrogen. (Grand Island, NY), followed by
three washes in PBSTx for 10 min each. Finally, the cells were mounted
in Prolong gold antifade reagent with DAPI. Images were taken under
40X and 60X objective using the Olympus BX51 microscope.

2.1.3. Quantitative RT-PCR
Gene expression levels in tissue samples were measured by two-step
qRT-PCR. Total RNA was isolated from liver, small intestine tissue and
cells grown in a monolayer by homogenization in TRIzol reagent
(Invitrogen) per the manufacturer's instructions and puriﬁed with the
use of RNeasy mini kit columns (Qiagen, Valencia, CA). Puriﬁed RNA
(1 μg) was converted to cDNA using iScript cDNA synthesis kit (BioRad) following the manufacturer's standard protocol. qRT-PCR was
performed with the gene-speciﬁc primers using SsoAdvanced SYBR
Green supermix (Bio-Rad) and CFX96 thermal cycler (Bio-Rad).
Threshold Cycle (Ct) values for the selected genes were normalized
against 18S (internal control) values in the same sample. The relative
fold change was calculated by the 2−ΔΔCt method (Table 1).

2.1.4. Western Blotting
SDS PAGE-Resolved protein bands were transferred to nitrocellulose
membrane using precut nitrocellulose/ﬁlter paper sandwiches (Bio-Rad
Laboratories, Hercules, CA) and Trans-Blot Turbo transfer system (BioRad) in case of low molecular weight proteins and using wet transfer
module from Invitrogen for high molecular weight proteins. Primary
antibodies (Abcam) were used at recommended dilutions, and compatible horseradish peroxidase-conjugated secondary antibodies were
used. Pierce ECL Western Blotting substrate (Thermo Fisher Scientiﬁc,
Rockford, IL) was used for detection. The blot was imaged using G:Box
Chemi XX6 (Syngene imaging systems) and subjected to densitometry
analysis using Image J.

2. Materials and methods
Table 1
Primer sequences for the genes used for real time mRNA quantitation.

2.1. Animal model
2.1.1. Mice model for NAFLD
Pathogen-free, adult, male mice with C57BL/6J background
(Jackson Laboratories, Bar Harbor, ME) were used in the study. They
were fed with a high-fat diet (60% kcal fat) (Research diets, New
Brunswich, NJ) for 18 weeks and used as a model of nonalcoholic fatty
liver disease (NAFLD). Mice kept on a similar diet for 4 weeks served as
a model for early NAFLD (DIO) where mild steatosis was evident with
no liver inﬂammation, normal chow diet was used as a model of lean
controls. Mice that contained the disrupted p47 phox (B6.129S2Ncf1tm1shl N14) gene were treated like the NAFLD group
(Supplementary material). All groups of mice had ad libitum access
to food and water. All animals were treated in strict accordance with
the NIH Guide for the Humane Care and Use of Laboratory Animals,
and the experiments were approved by the institutional review board at
the University of South Carolina at Columbia.
2.1.2. Immunohistochemistry and immunoﬂuorescence
Formalin-ﬁxed, paraﬃn-embedded intestinal and liver tissue from
all the mice groups were cut into 5 µm thick tissue sections. Each
section was deparaﬃnized (Supplementary material). Epitope retrieval
of deparaﬃnized sections was carried out using epitope retrieval
solution and steamer (IHC-World, Woodstock, – MD) following the
9

Target

Species

Sequence 5′-3′

HMGB1 F
HMGB1 R
MCP-1 F
MCP-1 R
IL-1β F
IL-1β R
TGF-β F
TGF-β R
IFN-γ F
IFN-γ R
RAGE F
RAGE R
18SF
18SR
IL-1β F
IL-1β R
IL-6 F
IL-6 R
P47Phox F
P47Phox R
MCP-1 F
MCP-1 R
18SF
18SR

Mus musculus
Mus musculus
Mus musculus
Mus musculus
Mus musculus
Mus musculus
Mus musculus
Mus musculus
Mus musculus
Mus musculus
Mus musculus
Mus musculus
Mus musculus
Mus musculus
Rattus norvegicus
Rattus norvegicus
Rattus norvegicus
Rattus norvegicus
Rattus norvegicus
Rattus norvegicus
Rattus norvegicus
Rattus norvegicus
Rattus norvegicus
Rattus norvegicus

GGACTCTCCTTTAACCGC
TTGTGATAGCCTTCGCTGGG
GTAGCAGCAGGTGAGTGGGGC
CACAGTTGCCGGCTGGAGCAT
CCTCGGCCAAGACAGGTCGC
TGCCCATCAGAGGCAAGGAGGA
CTCACCGCGACTCCTCCTGCTGC
TCGGAGAGCGGGAACCCTCG
TGCGGGGTTGTATCTGGGGGT
GCGCTGGCCCGGAGTGTAGA
CTGGTGGGACTGTGACCTTG
CCTCTGCCTGTCATTCCTAGC
TTCGAACGTCTGCCCTATCAA
ATGGTAGGCACGGCGATA
CCCTGCAGCTGGAGAGTGTGG
TGTGCTCTGCTTGAGAGGTGCT
CGAGCCCACCAGGAACGAAAGTC
CTGGCTGGAAGTCTCTTGCGGAG
AGCCCTGACTCAAAGGGTGA
TAGTCCTGATCCCACCCCTA
TAGCATCCACGTGCTGTCTC
CAGCCGACTCATCATTGGGATCA
GGATCCATTGGAGGGCAAGT
ACGAGCTTTTTAACTGCAGCAA

Redox Biology 13 (2017) 8–19

V. Chandrashekaran et al.

Fig. 1. NAFLD liver leads to HMGB1 release in the blood. A. HMGB1 immunoreactivity as shown by immunohistochemistry in liver slices from mice fed with chow diet as a model of lean
control (LC), high-fat diet (60% kcal fat) for 4 weeks as a model of early NAFLD (DIO) and 16 weeks as a model nonalcoholic fatty liver disease (NAFLD). Images were taken at 20×
magniﬁcation. B. Morphometric analysis of HMGB1 immunoreactivity (mean data from three separate microscopic ﬁelds were plotted on Y-axis in LC, DIO and NAFLD groups of mice
(**P < 0.05, ***P < 0.01)). C. mRNA expressions of HMGB1 in liver tissue of LC, DIO and NAFLD groups of mice assessed by quantitative real time PCR, the expressions were normalized
with 18 s and compared to the LC group and represented as fold changes to LC (**P < 0.05, ***P < 0.01). D. Western blot analysis of HMGB1 protein levels in the serum. Lanes 1–3
represent LC, DIO and NAFLD groups E. Band quantiﬁcation of the HMGB1 immunoblot in LC, DIO and NAFLD groups of mice, data was normalized against Albumin (**P < 0.05,
***P < 0.01).

2.1.5. Cell culture
Immortalized rat intestinal epithelial cells (IEC-6) were purchased
from ATCC (CRL-1592) was maintained in high glucose Dulbelcos
modiﬁed eagles medium (DMEM), Corning (Tewksbury, MA) supplemented with 10% fetal bovine serum (FBS), Atlanta biologicals
(Norcross, GA) suplimented with 2 mM glutamine, 0.1 U/ml Insulin,
100 U/ml Penicillin, and 100 μg/ml streptomycin; Gibco (Grand Island,
NY) at 37 °C in a humidiﬁed atmosphere of 5% CO2. The cells were then
treated with recombinant rat HMGB1 (Mybiosource. San Diego, CA)
30 ng/ml a cytokine mediator of inﬂammation released by activated
macrophages able to bind to and activate RAGE & TLR4, Apocynin
(Sigma-Aldrich) 100 µM an inhibitor of NADPH oxidase activity and
thus preventing production of superoxide, RAGE antagonist (FPS-ZM1,
Milipore, MA) 200 nM V-domain ligand binding RAGE inhibitor,
Peroxynitrite (Cayman Chem, Ann Arbor, MI) 300 µM a highly reactive
structural isomer of nitrate, Phenyl Boronic Acid (FBA) (Sigma Aldrich)
100 µM was used as a scavenger for Peroxynitrite, PI3K inhibitor
(LY294002, Sigma Aldrich) 10 µM as an inhibitor for AKT phosphorylation as required.

the Bonferroni posthoc correction for intergroup comparisons.
Quantitative data from western blots as depicted by the relative
intensity of the bands were analyzed by performing a student's t-test.
3. Results
Fatty liver causes the release of damage associated molecular
pattern HMGB1 [11,15]. To study the levels of HMGB1 in the liver
following development of fatty liver, C57BL6/J mice were fed with high
fat diet for 18 weeks. HFD-fed mice showed insulin and leptin
resistance, macrovesicular steatosis, inﬂammation and little or no
ﬁbrosis, a condition that resemble most NAFLD patients. NAFLD mice
had markedly increased lobular inﬂammation as shown by hematoxylin
eosin staining and lipid droplets when compared to both an early time
point with no signiﬁcant steatosis (4 weeks of HFD) (DIO group) or lean
controls (LC group) (Supplementary material Fig. 1A–C). NAFLD mice
showed signiﬁcantly increased localization and protein levels of
HMGB1 in the liver with higher immunoreactivity in both hepatocytes
and sinusoidal spaces when compared to DIO (p=0.007) and LC groups
(p < 0.001) (Fig. 1A and B). mRNA expression of HMGB1 was
signiﬁcantly higher in the NAFLD liver when compared to both DIO
and LC groups showing that HMGB1 protein was endogenous to the
diseased liver (Fig. 1C). Mice with fatty liver disease (NAFLD) had
signiﬁcantly increased serum HMGB1 levels as analyzed by western

2.1.6. Statistical analysis
All experiments were repeated three times with 3 mice per group
(N=3; data from each group of mice was pooled). The statistical
analysis was carried out by analysis of variance (ANOVA) followed by
10
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blot analysis and band quantiﬁcation when compared with both LC
(> 3 fold) and DIO (> 2 fold) groups (Fig. 1D and E).

HMGB1-only treatment (Fig. 3A, Supplementary material Fig. 3A).
HMGB1-primed cells had signiﬁcantly higher immunoreactivity of
tyrosine nitration indicating a possible role of peroxynitrite that is
NOX2 dependent when compared to vehicle control and cells treated
with apocynin (Fig. 3B, Supplementary material Fig. 3B). To conﬁrm
the role of HMGB1 in NOX2 driven TLR4 traﬃcking, HMGB1 primed
cells were assessed for TLR4-Flotillin colocalization using immunoﬂuorescence microscopy. Results showed that HMGB1-primed cells had
signiﬁcant increase in TLR4-Flotillin colocalization events when compared to vehicle control and apocynin treatment (Fig. 3C,
Supplementary material Fig. 3C). The results suggested that HMGB1mediated NOX2 was involved in TLR4 traﬃcking into the lipid rafts, a
crucial event that drives intestinal inﬂammation in NAFLD.
TLR4 activation leads to an increase in the release of interleukins 1β
and 6, that have been found to have profound roles in intestinal
inﬂammation and IBD-like phenotype [27]. To study whether HMGB1activated NOX2 was involved in the release of IL1β and IL6, mRNA
expressions of these cytokines were assessed from cell lysates primed
with HMGB1. Results showed that HMGB1-primed cells had signiﬁcantly increased IL1β and IL6 mRNA expression when compared to
vehicle control (p < 0.001) and HMGB1-primed cells treated with
Apocynin (p < 0.001) (Fig. 3D and E). The results suggested that
HMGB1-induced NOX2 activation increases expression of TLR4-pathway cytokines IL1β and IL6.

3.1. Increased circulatory HMGB1 in NAFLD correlates well with
peroxynitrite generation, TLR4 traﬃcking to lipid rafts and intestinal
inﬂammation in a NOX2 dependent manner
To study the role of circulatory HMGB1 in NAFLD in intestinal
inﬂammation, mouse intestinal tissue was evaluated for the mechanism
of ectopic inﬂammation. Results showed that there was a signiﬁcant
increase in the levels of MCP-1, TGF-β, IL1β and IFN-γ when assessed
by immunohistochemistry in the NAFLD group when compared to both
LC and DIO groups (Fig. 2A). Further, mRNA levels of the above
cytokines increased signiﬁcantly (p < 0.001) in NAFLD group when
compared to both LC and DIO groups respectively suggesting the
endogenous nature of the inﬂammation (Fig. 2B). Both increased levels
of mRNA and protein of the cytokines were signiﬁcantly decreased
(p < 0.001) in p47 phox knockout mice when compared to NAFLD mice
suggesting that the inﬂammation was NOX-2 dependent (Fig. 2A and
B). To study whether NOX2 was activated in the small intestine,
experiments were performed to assess the membrane assembly of the
NOX2 subunits p47 phox and gp91 phox using immunoﬂuorescence
microscopy and co-localization studies. Results suggested that the
number of colocalization events of gp91 phox and p47 phox in the
intestinal membrane were signiﬁcantly higher in NAFLD group when
compared to both LC and DIO groups (Fig. 2C and Supplementary
material Fig. 2A) while deletion of the p47 phox gene caused a
signiﬁcant decrease in the membrane assembly (Fig. 2C and
Supplementary material Fig. 2A) suggesting a strong NOX2 activation
in the NAFLD intestine. Since we have shown the role of NOX2 in
peroxynitrite formation in NAFLD, studies were conducted to show the
levels of 3-nitrotyrosine in the NAFLD intestine and whether the
tyrosine nitration by peroxynitrite was NOX-2 dependent. Results
showed that there was a signiﬁcant increase in 3-nitrotyrosine levels
in the NAFLD intestine group when compared to both LC and DIO
groups (Fig. 2D and Supplementary material Fig. 2B). 3-nitrotyrosine
levels were signiﬁcantly decreased in the P47 phox knockout mice
suggesting that the tyrosine nitration from primarily peroxynitrite
generation was NOX-2 dependent though other non-peroxynitrite
sources of 3-nitrotyrosine generation cannot be ruled out at this point
(Fig. 2D and Supplementary material Fig. 2B).
We have shown previously that NOX-2 drives TLR4 traﬃcking into
the lipid rafts [26]. To study the role of NOX2 in TLR4 traﬃcking to
lipid rafts and conﬁrming the role of NOX2-mediated TLR4 pathway in
inﬂammation of the intestine, TLR4-Flotillin colocalization were
assessed in the NAFLD intestines. Results showed that the number of
TLR4-Flotillin colocalizations were signiﬁcantly increased in the
NAFLD intestines when compared to both LC and DIO tissues (Fig. 2E
and Supplementary material Fig. 2C) while there was a signiﬁcant
decrease in the above colocalization events in the p47 phox knock mice
intestines suggesting a NOX-2 derived TLR4 traﬃcking (Fig. 2E and
Supplementary material Fig. 2C). NAFLD group also showed higher
Claudin-2 protein levels, a hallmark of IBD-like phenotype when
compared to lean and DIO groups (Fig. 2F). P47 phox deletion reversed
the changes observed in Claudin-2 levels (Fig. 2F).

3.3. Peroxynitrite drives TLR4 traﬃcking into lipid rafts via the AKT
pathway
Results obtained both invivo and invitro (Figs. 1–3) suggested a
possible role for NOX2 derived peroxynitrite in TLR4 activation and
release of IL1b and IL6. To study the involvement of peroxynitrite and
its activation of AKT pathway for TLR4-traﬃcking into the lipid rafts,
experiments were designed in vitro to conﬁrm this mechanism. Results
showed that cells primed with peroxynitrite caused a signiﬁcant
increase in TLR4-Flotillin colocalization events when compared to
vehicle control (Fig. 4A, Supplementary material Fig. 4A). Cells primed
with peroxynitrite but treated with speciﬁc peroxynitrite scavenger
phenyl boronic acid (FBA) showed a signiﬁcant decrease in TLR4Flotillin colocalization events when compared to peroxynitrite-only
primed cells (Fig. 4A, Supplementary material Fig. 4A). To show the
role of AKT in peroxynitrite-induced TLR4 traﬃcking into lipid rafts,
cells were treated with PI3K inhibitor. Results showed that peroxynitrite primed cells and PI3K inhibitor showed a signiﬁcant decrease in
TLR4 traﬃcking into lipid rafts as indicated by decreased TLR4-Flotillin
colocalization events (Fig. 4A, Supplementary material Fig. 4A).
To show that peroxynitrite caused AKT phosphorylation in IE6 cells,
experiments were performed to study the phosphorylation in AKT and
was compared to total AKT levels in the cell lysate. Results showed that
AKT phosphorylation peaked at 40 min post priming with peroxynitrite
(Fig. 4B; Supplementary material Fig. 4B). Thus, results from Fig. 4A
and B suggested a strong role of peroxynitrite-induced AKT phosphorylation in TLR4 activation a key event in IE6 cells. To study whether
peroxynitrite-induced AKT phosphorylation and TL4 activation was
involved in the proinﬂammatory phenotype in intestinal epithelial
cells, mRNA expression of IL1β and IL6 were observed. Results showed
that mRNA expression of IL1β and IL6 were increased signiﬁcantly
(p < 0.001) in peroxynitrite primed IE6 cells when compared to vehicle
controls (Fig. 4C and D). Cell treated with peroxynitrite scavenger FBA
or AKT inhibitor had signiﬁcantly decreased (p < 0.001) expressions of
IL1β and IL6 when compared to peroxynitrite-only group (Fig. 4C and
D).

3.2. HMGB1 primes NOX2 activation and TLR4-derived inﬂammation in
intestinal epithelial cells
To study the mechanism of HMGB1 induced NOX2 activation and
subsequent inﬂammation in the intestine, experiments were performed
in intestinal epithelial cells (IE6). Results showed that cells primed with
HMGB1 showed a signiﬁcant increase in p47 phox-gp91 colocalization
events when compared to vehicle control (Fig. 3A, Supplementary
material Fig. 3A). HMGB1 primed cells treated with apocynin had
signiﬁcantly decreased colocalization events when compared to

3.4. HMGB1 binding to RAGE causes NOX2 activation and peroxynitrite
generation
To study the levels of RAGE in NAFLD intestines, qRTPCR was
11
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conducted from tissue lysates. Results showed that NAFLD intestines
showed a 35-fold increase in RAGE mRNA expression when compared
to lean controls (Fig. 5A) and a > 2-fold increase when compared to
DIO group (which does not show liver disease based on NASH scores).
Intestinal epithelial cells showed a signiﬁcant increase in P47Phox
expression (> 5 fold) when primed with HMGB1 but had signiﬁcantly
decreased P47Phox expression following incubation with a speciﬁc
RAGE-antagonist (Fig. 5B). IE6 cells primed with HMGB1 showed
signiﬁcantly increased gp91phox-p47 phox colocalization suggesting a
strong NOX2 activation when compared to vehicle controls (Fig. 5C and

Supplementary material Fig. 5C). To ensure the speciﬁcity of HMGB1RAGE binding we denatured the HMGB1 by boiling the protein for
60 min. Also, we used a speciﬁc antagonist of RAGE as a dual approach.
Results showed that NOX2 activation was signiﬁcantly inhibited using
RAGE antagonist and denatured HMGB1 as shown by decreased gp91p47 phox colocalization events (Fig. 5C and Supplementary material
Fig. 5A). Tyrosine nitration which is a possible result from peroxynitrite
dependent redox pathway was signiﬁcantly increased in HMGB1primed cells when compared to vehicle controls (Fig. 5D and
Supplementary material Fig. 5B). Incubation with either a speciﬁc

Fig. 2. NAFLD intestines have increased inﬂammation mediated by NADPH oxidase activity and TLR-4 recruitment. A.MCP-1, TGF-β, IL-1β and IFN-γ immunoreactivity as shown by
immunohistochemistry in intestinal slices from LC, DIO, NAFLD mice. Mice lacking a functional P47 Phox sub-unit fed on high-fat diet (60% kcal fat) for 16 weeks (P47Phox KO). Images
were taken at 20× magniﬁcation. B. mRNA expressions of MCP-1, TGF-β, IL-1β and IFN-γ in intestinal tissue of LC, DIO, NAFLD and P47Phox KO groups of mice as assessed by
quantitative real time PCR, the expressions were normalized with 18 s and compared to the LC group and represented as fold changes to LC (**P < 0.05, ***P < 0.01). C.
Immunoﬂuorescence for P47Phox (Green) and GP-91 Phox (Red) co-localization in intestinal sections of LC, DIO, NAFLD and P47Phox KO mice (60× images). D. Immunoﬂuorescence for
3-Nitro-Tyrosine (Red) in intestinal sections of LC, DIO, NAFLD and P47Phox KO mice (20×). E. Immunoﬂuorescence for Flotilin (Green) and TLR-4 (Red) co-localization in intestinal
sections of LC, DIO, NAFLD and P47Phox KO mice (60× images). F. immunoﬂuorescence for Claudin-2 protein levels in LC, DIO, NAFLD and P47Phox KO mice (60× images) as shown
by red stain. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 2. (continued)

RAGE antagonist or use of denatured HMGB1 signiﬁcantly decreased
tyrosine nitration when compared to HMGB1 primed cells (Fig. 5D and
Supplementary material Fig. 5B) suggesting that HMGB1-RAGE binding
was responsible for NOX2 activation and peroxynitrite generation.

3.5. HMGB1 binding to RAGE causes TLR4 activation and
proinﬂammatory cytokine release
Following the results of HMGB1-RAGE activation of NOX2 and
peroxynitrite generation, it was imperative that we study the above
pathway for TLR4 activation and proinﬂammatory events in the
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Fig. 3. HMGB1 leads to TLR-4 recruitment and activation via NADPH oxidase in IEC-6 cells. A. Immunoﬂuorescence for P47Phox (Green) and GP-91 Phox (Red) co-localization in
intestinal epithelial cells (IEC-6) treated with HMGB1 30 ng/ml (HMGB1), and HMGB1+Apocynin 100 µM (HMGB1+Apo) (40× images). B. Immunoﬂuorescence for 3-Nitro-Tyrosine
(Red) in intestinal epithelial cells (IEC-6) treated with HMGB1 30 ng/ml (HMGB1), and HMGB1+Apocynin 100 µM (HMGB1+Apo) (40× images). C. Immunoﬂuorescence for Flotilin
(Green) and TLR-4 (Red) co-localization in intestinal epithelial cells (IEC-6) treated with HMGB1 30 ng/ml (HMGB1), and HMGB1+Apocynin 100 µM (HMGB1+Apo) (40× images). D
and E. mRNA expressions of IL-1β and IL-6 in intestinal epithelial cells (IEC-6) treated with HMGB1 30 ng/ml (HMGB1), and HMGB1+Apocynin 100 µM (HMGB1+Apo) as assessed by
quantitative real time PCR, the expressions were normalized with 18 s and compared to the control group and represented as fold changes to Ctrl (**P < 0.05, ***P < 0.01). (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)

intestinal cells. Results showed that HMGB1 primed cells showed
signiﬁcant increase in TLR4-Flotillin colocalization that was blunted
in the presence of a speciﬁc RAGE antagonist and use of denatured
HMGB1 (Fig. 6A and Supplementary material Fig. 6A). Use of RAGE
antagonist blunted TLR4 ﬂotillin colocalization also implied that
HMGB1-binding to TLR4 was not a predominant pathway in the IE6
cells (Fig. 6A). The signiﬁcant (p < 0.001) increase in IL1β and IL6
mRNA expression by IE6 cells following HMGB1 priming was signiﬁcantly decreased (p < 0.001) using speciﬁc antagonist against RAGE
and the use of denatured HMGB1 suggesting that HMGB1-RAGE

binding was instrumental in proinﬂammatory cytokine expression
(Fig. 6B and C). Since monocyte chemoattractant protein (MCP1) also
plays a role in an inﬂammatory microenvironment, mRNA expression
analysis of MCP1 was assayed in IE6 cells. Results showed that MCP1
expression was signiﬁcantly increased (p < 0.001) following HMGB1
priming (> 40 fold) when compared to vehicle controls (Fig. 6D). Use
of an antagonist for RAGE or use of denatured HMGB1 which has lost its
binding ability to RAGE signiﬁcantly (p < 0.001) decreased expression
of MCP1 mRNA suggesting that HMGB1-RAGE interaction increased
possibility of a proinﬂammatory microenvironment (Fig. 6D).
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Fig. 4. Peroxynitrite leads to TLR-4 recruitment and activation by phosphorylation of AKT. A. Immunoﬂuorescence for Flotilin (Green) and TLR-4 (Red) co-localization in intestinal
epithelial cells (IEC-6) treated with peroxynitrite 300 µM (Peroxy) and combinations with phenyl Boronic acid 100 µM (Peroxy+FBA) and AKT inhibitor 10 µM (Peroxy+ AKTi) (40×
images). B. Western blot analysis of p-AKT protein levels in IEC-6 cells treated with peroxynitrite with and without Phenylboronic acid. Lanes 1–3 represent Control samples, Lanes 4–6
represent cells treated with peroxynitrite 300 µM and Lanes 7–9 represent cells treated with peroxynitrite and phenylboronic acid 100 µM. Proteins were harvested at 20 m, 40 m and
60 m time interval. The bands obtained were normalized to Total AKT. C and D. mRNA expressions of IL-1β and IL-6 in intestinal epithelial cells (IEC-6) treated with peroxynitrite
300 µM, and combinations with Phenyl Boronic acid 100 µM and AKT inhibitor 10 µM. HMGB1+Apocynin 100 µM as assessed by quantitative real time PCR, the expressions were
normalized with 18 s and compared to the control group and represented as fold changes to Ctrl (**P < 0.05, ***P < 0.01). (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)

4. Discussion

increased release of MCP-1, a chemokine known to attract neutrophils.
NAFLD and its progressive inﬂammatory phase nonalcoholic steatohepatitis has been associated with intestinal inﬂammation resembling
an IBD phenotype and colonic neoplasia [2]. Interestingly, steatosis or
benign fat deposition in the liver was not found to be associated with
neoplasia [2]. Our results where DIO group represented a benign
steatosis group showed no intestinal inﬂammation or cytokine release
thus conforming to the clinical data. This event may be ascribed to less

We present a novel pathological pathway of ectopic inﬂammation in
the intestine following development of progressive NAFLD that is
mediated by a) circulatory HMGB1-RAGE interaction and b) NOX2Peroxynitrite-mediated TLR4 activation. The HMGB1-RAGE-mediated
NOX2 activation and subsequent peroxynitrite induced TLR4 traﬃcking
into the lipid rafts caused higher expression of IL1β and IL6 followed by
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Fig. 5. HMGB1 generates peroxynitrite via NADPH oxidase by speciﬁcally binding to RAGE. A. mRNA expressions of RAGE in intestinal tissue of LC, DIO and NAFLD groups of mice as
assessed by quantitative real time PCR, the expressions were normalized with 18 s and compared to the LC group and represented as fold changes to LC (**P < 0.05, ***P < 0.01). B.
mRNA expressions of P47Phox in intestinal epithelial cells (IEC-6) treated with HMGB1 30 ng/ml (HMGB1), and HMGB1+RAGE Antagonist 200 nM (HMGB1+RAGEAn) as assessed by
quantitative real time PCR, the expressions were normalized with 18 s and compared to the control group and represented as fold changes to Ctrl (**P < 0.05, ***P < 0.01). C.
Immunoﬂuorescence for P47Phox (Green) and GP-91 Phox (Red) co-localization in intestinal epithelial cells (IEC-6) treated with HMGB1 30 ng/ml (HMGB1), HMGB1+ RAGE Antagonist
200 nM (HMGB1+RAGE An) and denatured HMGB1 30 ng/ml (HMGB1 des) (40× images). D. Immunoﬂuorescence for 3-Nitro-tyrosine (Red) co-localization in intestinal epithelial cells
(IEC-6) treated with HMGB1 30 ng/ml (HMGB1), HMGB1+ RAGE Antagonist 200 nM (HMGB1+RAGE An) and denatured HMGB1 30 ng/ml (HMGB1 des) (40× images). (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)

HMGB1 in the liver and subsequent decreased circulatory HMGB1
levels following decreased liver cell necrosis. Thus, a progressive
NAFLD with lobular inﬂammation as seen in our results paves way
for higher circulatory HMGB1 and is a ligand for a series of proinﬂammatory events in the intestinal epithelial cells. The results also link
the strong inﬂammatory phenotype observed in NAFLD intestines in
our studies.
Though a strong association was observed in patients with NAFLD/
NASH to development of colonic inﬂammation or studies that found
NAFLD associations with IBD phenotype, the mechanisms that link

these two inﬂammatory events were unclear [2,3]. Interestingly, there
are considerable reports of circulatory cytokines, lack of adiponectin or
increased leptin in NAFLD that are proinﬂammatory in nature but a
direct mechanistic link to colonic inﬂammation is scarce [28]. Our
observation that high circulatory HMGB1 in absence of signiﬁcant other
organ injuries probably originates in the damaged liver bodes well for a
prominent role of this DAMP in causing ectopic intestinal inﬂammation.
DAMPS has been found to play a prominent role in inﬂammation in
many diseases [29]. However caution should be exercised when
interpreting the data since prolonged feeding with high fat diet has
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Fig. 6. HMGB1 recruits and activates TLR-4 by binding to RAGE. A. Immunoﬂuorescence for Flotilin (Green) and TLR-4 (Red) co-localization in intestinal epithelial cells (IEC-6) treated
with HMGB1 30 ng/ml (HMGB1), HMGB1+ RAGE Antagonist 200 nM (HMGB1+RAGE An) and denatured HMGB1 30 ng/ml (HMGB1 des) (40× images). B–D. mRNA expressions of IL1β, IL-6 and MCP-1 in intestinal epithelial cells (IEC-6) treated with HMGB1 30 ng/ml (HMGB1), and HMGB1+Apocynin 100 µM (HMGB1+Apo) as assessed by quantitative real time
PCR, the expressions were normalized with 18 s and compared to the control group and represented as fold changes to Ctrl (**P < 0.05, ***P < 0.01). (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of this article.)

been associated with inﬂammatory lesions in the intestine [30]. Further
the present study is limited in specifying the role of circulatory HMGB1
in causing ectopic inﬂammation in the intestine since we have
unpublished data where intestinal HMGB1 was markedly increased
following high fat feeding though it was signiﬁcantly less than the
circulatory levels of HMGB1. Future studies would have to focus on
generating models that would clearly illustrate the source of HMGB1.
Sterile inﬂammation in the liver is found to be associated with HMGB1
and other DAMPs [31]. The above fact is supported by our results that
show liver HMGB1 levels are signiﬁcantly high in NAFLD and little or
no HMGB1 protein levels were detectable in the heart or kidney in our
model of high fat fed mouse model of NAFLD.
HMGB1 is known for its proinﬂamamtory role in the intestine and
other tissues including liver [10,31,32]. High circulatory levels of
HMGB1 was associated with increased expression of proinﬂammatory
mediators IL1β, MCP1, TGF-β and IFN-γ [11,33]. High HMGB1 was also
associated with NOX2 activation and increased 3-nitro tyrosine formation, a marker of peroxynitrite-mediated nitrative stress [34–36]. The
above events decreased signiﬁcantly in p47 phox knockout mice.
Peroxynitrite formation and TLR4 traﬃcking to the lipid rafts also
decreased in P47 phox knockout mice thus indicating that the proinﬂammatory events including TLR4 traﬃcking was dependent on NOX2.
This was intriguing since HMGB1 is known to bind TLR4 in generating a
proinﬂammatory cascade. Our results also implied that if HMGB1 and
redox signaling events were to generate an inﬂammatory phenotype in
the intestine, it had to do so by activating NOX2. Studies suggest that
HMGB1 can induce an activation of NOX2 by a Mac-1 dependent
pathway but in contrast can also induce phosphorylation of p40 subunit
of NOX2, thereby inhibiting its activation through a RAGE dependent
pathway in neutrophils [36,37]. With HMGB1 levels being associated
with increased NOX2 activation in the intestine we resorted to study the
redox pathway of inducing TLR4 signaling in our studies. Results
showed that HMGB1-primed intestinal epithelial cells activated

NOX2, formed higher nitration of tyrosine residues, increased TLR4
traﬃcking into lipid rafts and caused higher expression of proinﬂammatory cytokines IL1β and IL6, events that were blocked by use of
NOX2 inhibitor apocynin. Thus, HMGB1-NOX2 activation was upstream to TLR4 activation and the results opened the possibility of a
non-TLR4 based mechanism in our studies. Use of AKT inhibitor also
blocked peroxynitrite mediated TLR4 traﬃcking suggesting NOX2peroxynitrite-AKT signaling as a primary pathway for TLR4-mediated
inﬂammation in the intestinal epithelial cells.
RAGE has been found to bind HMGB1 in the B box binding region
[19]. The three redox states of HMGB1 diﬀer by structure, half-life, and
activity. The redox states determine the stability of HMGB1 and its
binding to either RAGE or TLR4 [19]. We found higher RAGE
expression in the NAFLD intestines. Our results also showed decreased
NOX2 activation, peroxynitrite formation, TLR4 traﬃcking and proinﬂammatory mediator expression in RAGE antagonist treated HMGB1
primed intestinal epithelial cells suggesting strongly that HMGB1
mediates its eﬀect through RAGE binding. Further the decreased and
almost negligible TLR4 traﬃcking in the presence of RAGE antagonist
proved that HMGB1-RAGE binding but not HMGB1-TLR4 caused the
inﬂammatory events in the cells. HMGB1 mediated eﬀects were further
conﬁrmed using denatured HMGB1 primed cells.
Though our results support strongly the involvement of circulatory
HMGB1-mediated inﬂammation in the NAFLD intestine, several questions remain unanswered. Firstly a high fat diet induced NAFLD model
that we have used in the present study is a slow and progressive inducer
of liver disease pathology [38]. Such models cause obesity and insulin
resistance and has been shown to alter gut microbiome and dysbiosis. It
is shown in clinical studies that dysbiosis is associated with IBD like
phenotype which can cause liver disease by itself [3,28]. This fact
complicates our interpretation that HMGB1 was primarily derived from
liver and did not originate from the intestine. Most murine models of
NAFLD cause gut dysbiosis and there is hardly a way that a liver disease
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Appendix A. Supplementary material
Supplementary data associated with this article can be found in the
online version at http://dx.doi.org/10.1016/j.redox.2017.05.005.
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Fig. 7. HMGB1 released from NAFLD liver reaches and binds to RAGE receptors in the
intestines activating it via circulation, leading to NADPH oxidase complex assembly on
the membrane generating Peroxynitrite, The Peroxynitrite thus generated phosphorylates
AKT leading to TLR-4 recruitment in the lipid rafts in the cell membrane, where it can
bind to HMGB1 leading to transcription of inﬂammatory cytokines such as IL-6 and IL-1β.

phenotype is established where the intestine is unaﬀected. Secondly,
HMGB1-TLR4 pathway is favored because of the increased stability of
HMGB1 [19]. This event does not rule out the HMGB1-TLR4-mediated
inﬂammation in other cell types of the intestine since we studied the
pathways only in the intestinal epithelial cells.
Taken together, our data in both an in vivo and in vitro setting
shows a novel HMGB1-RAGE mediated redox signaling pathway that
exerts its eﬀect through peroxynitrite induced AKT phosphorylation
which in turn directs TLR4 to lipid rafts (Fig. 7). The ensuing event
caused uninterrupted inﬂammation through release of IL1β, IL6 and
MCP1 and resulted in an IBD-like phenotype. With recent published
studies including ours showing the eﬃcacy of speciﬁc peroxynitrite
scavenger phenyl boronic acid (FBA) in curbing NAFLD mediated
inﬂammation, it will be justiﬁed to assume that FBA may be a likely
candidate for an interventional strategy to curb ectopic inﬂammatory
events in NAFLD or IBD itself [26]. The present study also ﬁnds a
probable mechanistic link to NAFLD induced intestinal neoplasia since
chronic inﬂammation such as that in NAFLD is deemed to be paramount
to such an event in humans.
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